192 related articles for article (PubMed ID: 24050266)
1. Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization.
Saxena N; Katiyar SP; Liu Y; Grover A; Gao R; Sundar D; Kaul SC; Wadhwa R
Biosci Rep; 2013 Oct; 33(5):. PubMed ID: 24050266
[TBL] [Abstract][Full Text] [Related]
2. Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways.
Ha JH; Shin JS; Yoon MK; Lee MS; He F; Bae KH; Yoon HS; Lee CK; Park SG; Muto Y; Chi SW
J Biol Chem; 2013 Mar; 288(10):7387-98. PubMed ID: 23316052
[TBL] [Abstract][Full Text] [Related]
3. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
Shin JS; Ha JH; Chi SW
Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
Moroy G; Martin E; Dejaegere A; Stote RH
J Biol Chem; 2009 Jun; 284(26):17499-511. PubMed ID: 19293158
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
[TBL] [Abstract][Full Text] [Related]
6. Discoveries and controversies in BCL-2 protein-mediated apoptosis.
Zheng JH; Viacava Follis A; Kriwacki RW; Moldoveanu T
FEBS J; 2016 Jul; 283(14):2690-700. PubMed ID: 26411300
[TBL] [Abstract][Full Text] [Related]
7. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.
Rehman K; Tariq M; Akash MS; Gillani Z; Qazi MH
Chem Biol Drug Des; 2014 Mar; 83(3):317-23. PubMed ID: 24118733
[TBL] [Abstract][Full Text] [Related]
8. Molecular mimicry-based repositioning of nutlin-3 to anti-apoptotic Bcl-2 family proteins.
Ha JH; Won EY; Shin JS; Jang M; Ryu KS; Bae KH; Park SG; Park BC; Yoon HS; Chi SW
J Am Chem Soc; 2011 Feb; 133(5):1244-7. PubMed ID: 21210687
[TBL] [Abstract][Full Text] [Related]
9. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
[TBL] [Abstract][Full Text] [Related]
10. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
[TBL] [Abstract][Full Text] [Related]
11. p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins.
Müer A; Overkamp T; Gillissen B; Richter A; Pretzsch T; Milojkovic A; Dörken B; Daniel PT; Hemmati P
J Biol Chem; 2012 May; 287(21):17343-17352. PubMed ID: 22354970
[TBL] [Abstract][Full Text] [Related]
12. Bh3 induced conformational changes in Bcl-Xl revealed by crystal structure and comparative analysis.
Rajan S; Choi M; Baek K; Yoon HS
Proteins; 2015 Jul; 83(7):1262-72. PubMed ID: 25907960
[TBL] [Abstract][Full Text] [Related]
13. Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity.
Primikyri A; Chatziathanasiadou MV; Karali E; Kostaras E; Mantzaris MD; Hatzimichael E; Shin JS; Chi SW; Briasoulis E; Kolettas E; Gerothanassis IP; Tzakos AG
ACS Chem Biol; 2014 Dec; 9(12):2737-41. PubMed ID: 25211642
[TBL] [Abstract][Full Text] [Related]
14. The DNA binding domain of p53 is sufficient to trigger a potent apoptotic response at the mitochondria.
Matissek KJ; Mossalam M; Okal A; Lim CS
Mol Pharm; 2013 Oct; 10(10):3592-602. PubMed ID: 23968395
[TBL] [Abstract][Full Text] [Related]
15. Reconstitution of the mitochondrial Hsp70 (mortalin)-p53 interaction using purified proteins--identification of additional interacting regions.
Iosefson O; Azem A
FEBS Lett; 2010 Mar; 584(6):1080-4. PubMed ID: 20153329
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mitochondrial permeability transition pore opening is involved in the protective effects of mortalin overexpression against beta-amyloid-induced apoptosis in SH-SY5Y cells.
Qu M; Zhou Z; Chen C; Li M; Pei L; Yang J; Wang Y; Li L; Liu C; Zhang G; Yu Z; Wang D
Neurosci Res; 2012 Jan; 72(1):94-102. PubMed ID: 22001761
[TBL] [Abstract][Full Text] [Related]
17. High-resolution analysis of the conformational transition of pro-apoptotic Bak at the lipid membrane.
Sperl LE; Rührnößl F; Schiller A; Haslbeck M; Hagn F
EMBO J; 2021 Oct; 40(20):e107159. PubMed ID: 34523144
[TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
19. Nuclear and cytoplasmic p53 suppress cell invasion by inhibiting respiratory complex-I activity via Bcl-2 family proteins.
Kim EM; Park JK; Hwang SG; Kim WJ; Liu ZG; Kang SW; Um HD
Oncotarget; 2014 Sep; 5(18):8452-65. PubMed ID: 25115399
[TBL] [Abstract][Full Text] [Related]
20. Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng.
Sathishkumar N; Sathiyamoorthy S; Ramya M; Yang DU; Lee HN; Yang DC
J Enzyme Inhib Med Chem; 2012 Oct; 27(5):685-92. PubMed ID: 21919598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
